TG Therapeutics SG&A Expense (Quarterly) Insights

TG Therapeutics Inc (TGTX)

16.48 -0.94 (-5.40%) USD | NASDAQ | May 17, 16:00

16.48 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
March 31, 2024	34.58M
December 31, 2023	31.15M
September 30, 2023	32.77M
June 30, 2023	30.72M
March 31, 2023	28.07M
December 31, 2022	22.50M
September 30, 2022	14.25M
June 30, 2022	12.64M
March 31, 2022	20.61M
December 31, 2021	32.41M
September 30, 2021	34.90M
June 30, 2021	34.02M
March 31, 2021	26.76M
December 31, 2020	43.86M
September 30, 2020	35.30M
June 30, 2020	14.43M
March 31, 2020	14.26M
December 31, 2019	7.056M
September 30, 2019	2.914M
June 30, 2019	2.716M
March 31, 2019	2.342M
December 31, 2018	1.912M
September 30, 2018	0.968M
June 30, 2018	5.683M
March 31, 2018	6.597M

Date	Value
December 31, 2017	5.077M
September 30, 2017	4.474M
June 30, 2017	1.757M
March 31, 2017	5.022M
December 31, 2016	1.782M
September 30, 2016	3.166M
June 30, 2016	2.528M
March 31, 2016	2.413M
December 31, 2015	2.424M
September 30, 2015	2.290M
June 30, 2015	5.888M
March 31, 2015	5.024M
December 31, 2014	3.622M
September 30, 2014	3.786M
June 30, 2014	5.146M
March 31, 2014	3.233M
December 31, 2013	1.461M
September 30, 2013	1.376M
June 30, 2013	1.639M
March 31, 2013	2.182M
December 31, 2012	1.525M
September 30, 2012	1.153M
June 30, 2012	1.459M
March 31, 2012	0.644M
December 31, 2011	0.5405M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.716M

Minimum

Jun 2019

43.86M

Maximum

Dec 2020

23.80M

Average

27.42M

Median

SG&A Expense (Quarterly) Benchmarks